Status: current, Defined. Date: 30-Apr 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4124041000168111 | Avandamet 2/500 (metformin hydrochloride 500 mg + rosiglitazone 2 mg) tablet, 14 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4124051000168113 | Avandamet 2/500 tablet, 14 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Avandamet 2/500 tablet, 14 | Is a | rosiglitazone 2 mg + metformin hydrochloride 500 mg tablet, 14 | true | Inferred relationship | Some | ||
| Avandamet 2/500 tablet, 14 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Avandamet 2/500 tablet, 14 | has TPUU | Avandamet 2/500 tablet | true | Inferred relationship | Some | 1 | |
| Avandamet 2/500 tablet, 14 | has TP | Avandamet 2/500 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Avandamet 2/500 tablet, 14, blister pack | Is a | True | Avandamet 2/500 tablet, 14 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR